Gemcitabine, dexamethasone, and cisplatin (GDP) is an effective and well-tolerated salvage therapy for relapsed/refractory diffuse large B-cell lymphoma and Hodgkin lymphoma
| Image |  |
|---|---|
| Description | scientific article published on 27 June 2016 |
| Author/s |
author: Graham W Slack Tamara N Shenkier Richard J Klasa Maryse M Power Joseph M Connors Laurie H Sehn Alden A Moccia Paul J Hoskins Randy D Gascoyne Kerry J Savage |
| Publication date | June 27, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |